132 related articles for article (PubMed ID: 38775841)
1. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
Morra S; Incesu RB; Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Creta M; Califano G; Collà Ruvolo C; Saad F; Shariat SF; Chun FKH; de Cobelli O; Musi G; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
World J Urol; 2024 May; 42(1):343. PubMed ID: 38775841
[TBL] [Abstract][Full Text] [Related]
2. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
[TBL] [Abstract][Full Text] [Related]
3. Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
Nazzani S; Preisser F; Mazzone E; Marchioni M; Bandini M; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
Clin Genitourin Cancer; 2019 Jun; 17(3):e602-e611. PubMed ID: 31005472
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
[TBL] [Abstract][Full Text] [Related]
5. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
[TBL] [Abstract][Full Text] [Related]
6. Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study.
Lec PM; Venkataramana A; Lenis AT; Fero KE; Sharma V; Golla V; Gollapudi K; Blumberg J; Chamie K
Urol Oncol; 2021 Mar; 39(3):194.e17-194.e24. PubMed ID: 33012575
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
[TBL] [Abstract][Full Text] [Related]
8. The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma.
Al Hussein Al Awamlh B; Shoag JE; Basourakos SP; Lewicki PJ; Posada L; Ma X; Raman JD; Shariat SF; Scherr D
Urology; 2021 Aug; 154():127-135. PubMed ID: 33766715
[TBL] [Abstract][Full Text] [Related]
9. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
[TBL] [Abstract][Full Text] [Related]
10. Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Soulières D; Montanari E; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
Eur Urol Focus; 2020 Mar; 6(2):298-304. PubMed ID: 30266210
[TBL] [Abstract][Full Text] [Related]
11. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
12. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.
Hall MC; Womack S; Sagalowsky AI; Carmody T; Erickstad MD; Roehrborn CG
Urology; 1998 Oct; 52(4):594-601. PubMed ID: 9763077
[TBL] [Abstract][Full Text] [Related]
14. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B
World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
[TBL] [Abstract][Full Text] [Related]
16. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
Zhai TS; Jin L; Zhou Z; Liu X; Liu H; Chen W; Lu JY; Yao XD; Feng LM; Ye L
BMC Cancer; 2019 Dec; 19(1):1207. PubMed ID: 31830927
[TBL] [Abstract][Full Text] [Related]
17. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
[TBL] [Abstract][Full Text] [Related]
18. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in upper tract urothelial carcinoma patients across the United States.
Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Siech C; Goyal JA; Touma N; Tian Z; Saad F; Califano G; la Rocca R; Capece M; Shariat SF; Ahyai S; Carmignani L; de Cobelli O; Musi G; Briganti A; Chun FKH; Longo N; Karakiewicz PI
Urol Oncol; 2024 May; 42(5):162.e1-162.e10. PubMed ID: 38336499
[TBL] [Abstract][Full Text] [Related]
20. Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Deuker M; Mistretta FA; Tian Z; Fossati N; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
J Surg Oncol; 2020 Jun; 121(7):1154-1161. PubMed ID: 32107785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
